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The number of discharge medications
predicts thirty-day hospital readmission: a
cohort study
David Picker1, Kevin Heard2, Thomas C. Bailey3, Nathan R. Martin4, Gina N. LaRossa4 and Marin H. Kollef1*
Abstract
Background: Hospital readmission occurs often and is difficult to predict. Polypharmacy has been identified as a
potential risk factor for hospital readmission. However, the overall impact of the number of discharge medications
on hospital readmission is still undefined.
Methods: To determine whether the number of discharge medications is predictive of thirty-day readmission using
a retrospective cohort study design performed at Barnes-Jewish Hospital from January 15, 2013 to May 9, 2013. The
primary outcome assessed was thirty-day hospital readmission. We also assessed potential predictors of thirty-day
readmission to include the number of discharge medications.
Results: The final cohort had 5507 patients of which 1147 (20.8 %) were readmitted within thirty days of their
hospital discharge date. The number of discharge medications was significantly greater for patients having a
thirty-day readmission compared to those without a thirty-day readmission (7.2 ± 4.1 medications [7.0 medications
(4.0 medications, 10.0 medications)] versus 6.0 ± 3.9 medications [6.0 medications (3.0 medications, 9.0 medications)];
P < 0.001). There was a statistically significant association between increasing numbers of discharge medications and
the prevalence of thirty-day hospital readmission (P < 0.001). Multiple logistic regression identified more than six
discharge medications to be independently associated with thirty-day readmission (OR, 1.26; 95 % CI, 1.17–1.36;
P = 0.003). Other independent predictors of thirty-day readmission were: more than one emergency department
visit in the previous six months, a minimum hemoglobin value less than or equal to 9 g/dL, presence of congestive
heart failure, peripheral vascular disease, cirrhosis, and metastatic cancer. A risk score for thirty-day readmission derived
from the logistic regression model had good predictive accuracy (AUROC = 0.661 [95 % CI, 0.643–0.679]).
Conclusions: The number of discharge medications is associated with the prevalence of thirty-day hospital
readmission. A risk score, that includes the number of discharge medications, accurately predicts patients at risk for
thirty-day readmission. Our findings suggest that relatively simple and accessible parameters can identify patients at
high risk for hospital readmission potentially distinguishing such individuals for interventions to minimize readmissions.
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Background
Hospital readmissions within thirty days of hospital dis-
charge occur often and are difficult to predict [1]. In re-
sponse to the recommendations in the 2007 Medicare
Payment Advisory Commission report, many hospitals
have dedicated staff efforts and resources in order to
identify patients at risk for readmission, as well as to pre-
vent such readmissions [1] (www.medpac.gov/documents/
jun07_entirereport.pdf (Accessed 27 June 2014)). The rec-
ommendations from the 2007 Medicare Payment
Advisory Commission became the basis for the Hospital
Readmissions Reduction Program in the Affordable Care
Act altering the criteria for hospital payment reimburse-
ment. The Centers for Medicare & Medicaid Services has
been charged with enforcement of these criteria by redu-
cing Medicare payments to hospitals that exceed preset
all-cause readmission rates [1]. For fiscal year 2013 the re-
admission penalties have been applied to three conditions:
acute myocardial infarction, heart failure, and pneumonia.
By 2015, the policy is expected to include readmissions for
chronic obstructive pulmonary disease, coronary artery
bypass graft surgery, percutaneous coronary interventions,
and other vascular procedures [2]. In fiscal year 2013, the
maximum payment reduction for hospitals with excess ra-
tios of actual to expected readmission rates was 1 % but in-
creases to 2 % in 2014, and to 3 % for 2015 and beyond [3].
Interventions aimed at preventing readmissions have
not been universally successful [4]. One potential ex-
planation for this is the inability to reliably predict
which patients are at risk for readmission in order to
target readmission prevention interventions. Predictors
of hospital readmission can be disease specific such as
presence of multivessel disease in patients hospitalized
with myocardial infarction [5] or more general such as
gender and lack of available follow-up post discharge
[6]. Polypharmacy has been identified as a risk factor
for readmission for patients discharged from internal
medicine services [7]. However, the overall impact of
the number of discharge medications on hospital re-
admission is still undefined. Therefore, we performed a
study to examine the influence of the number of dis-
charge medications on the prevalence of thirty-day
readmission.
Methods
Study location
The study was conducted on eight adult inpatient medi-
cine units of Barnes-Jewish Hospital, a 1250-bed aca-
demic medical center in St. Louis, MO (January 15,
2013 to May 9, 2013). Patient care on the inpatient
medicine units is delivered by either attending hospitalist
physicians or house staff physicians under the supervi-
sion of an attending physician. The study was approved
by the Washington University School of Medicine
Human Studies Committee and informed consent was
waived.
Study overview
We retrospectively evaluated all subjects admitted to
one of the eight adult inpatient medicine units of
Barnes-Jewish Hospital. The study only included adult
patients (aged >18 years) admitted through the emer-
gency department or transferred directly to the hospital
from other institutions. We further excluded patients
who died while hospitalized as they are necessarily not
at risk for readmission. All data was derived from the
hospital informatics database provided by the Center
for Clinical Excellence, BJC HealthCare. Medications
are provided to patients at the time of hospital dis-
charge either through the hospital pharmacy in the
form of a thirty-day supply or via a physician autho-
rized prescription to be filled at a local pharmacy.
Primary end point
Readmission for any reason (i.e., all-cause readmission)
to an acute care facility in the thirty days following dis-
charge after the initial hospitalization served as the pri-
mary end point. The index hospital serves as the main
teaching institution for BJC Healthcare, a large inte-
grated healthcare system of both inpatient and out-
patient care. The system includes a total of twelve
hospitals in a compact geographic region surrounding
and including St Louis, Missouri, and we included re-
admission to any of these hospitals in our analysis. Per-
sons treated within this healthcare system are, in nearly
all cases, readmitted to one of the system’s participating
twelve hospitals. If a patient who receives healthcare in
the system presents to a nonsystem hospital, he/she is
often transferred back into the integrated system be-
cause of issues of insurance coverage. Patients with a
thirty-day readmission were compared to those without
a thirty-day readmission.
Definitions and variables
Discharge medications were defined as all medications
prescribed by the patient’s treating physicians that were
required to be taken by the patient at the time of hospital
discharge. Discharge medications only included medica-
tions needing to be taken on a regular basis, did not
include any alternative non-prescribed medications such
as herbal or nutritional supplements, and did not include
over the counter medications that patients could purchase
on their own without a physicians’ prescription. Beyond
the number of discharge medications, we recorded
information regarding demographics, median income of
the zip code of residence as a marker of socioeconomic
status, admission to any BJC Healthcare facility within six
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months of the index admission, comorbidities, and
process of care variables. To assess a subject’s chronic
health state, we examined if they suffered from coronary
artery disease, chronic obstructive pulmonary disease, dia-
betes mellitus, dementia, had a history of a stroke, and
underlying malignancy. To represent the global burden
of comorbidities in each patient, we calculated their
Charlson scores [8].
Statistical analysis
The number of patients admitted to the eight adult
inpatient medicine units of Barnes-Jewish Hospital de-
termined the sample size. We used the Fisher exact test
or Student t test, as appropriate, for univariate analyses.
The Mann–Whitney U test was used for continuous,
nonparametrically distributed data. All analyses were
2-tailed, and a P value of < 0.05 was assumed to repre-
sent statistical significance. We relied on logistic regres-
sion for identifying variables independently associated
with thirty-day readmission. Based on univariate analysis,
variables significant at the P < 0.10 level were entered into
the model. To arrive at the most parsimonious model, we
utilized a stepwise backward elimination approach. We
evaluated colinearity with correlation matrices. We report
adjusted odds ratios (AORs) and 95 % confidence intervals
(CIs) where appropriate. The model’s goodness-of-fit was
assessed via calculation of the R2 value. We conducted a
cross-validation of the model in order to assess for overfit-
ting. We reran the logistic model on 90 % of the sample
sequentially dropping 10 % of the population with each
run. We contrasted the mean accuracy of these analyses
with the overall accuracy of the model developed with the
entire cohort. Cut-points of variables were determined
based on receiver-operating characteristic (ROC) curves.
All analyses were performed with SPSS software, version
19.0 (IBM SPSS, Chicago, Illinois).
Results
The final cohort had 5507 patients with a mean age of
56.1 ± 18.1 years and 2643 (48.0 %) males. The most
common reasons for hospital admission were sepsis syn-
drome including pneumonia and urinary tract infections
(21.4 %), congestive heart failure (16.1 %), respiratory
distress including chronic obstructive pulmonary disease
(13.4 %), acute or chronic renal failure (9.3 %), gastro-
intestinal disorders (8.8 %), and diabetes mellitus man-
agement (7.3 %). Overall, there were 1147 (20.8 %)
patients who were readmitted within thirty days of their
hospital discharge date.
The number of discharge medications was significantly
greater for patients having a thirty-day readmission com-
pared to those without a thirty-day readmission (7.2 ± 4.1
medications [7.0 medications (4.0 medications, 10.0 medi-
cations)] versus 6.0 ± 3.9 medications [6.0 medications
(3.0 medications, 9.0 medications)]; p < 0.001). Figure 1
demonstrates the distribution of thirty-day readmissions
according to the number of discharge medications. There
was a statistically significant association between increas-
ing numbers of discharge medications and the prevalence
of thirty-day hospital readmission. We also observed a dir-
ect correlation between increasing number of discharge
medications and emergency department visits in the six
months prior to the index hospitalization (Spearman’s co-
efficient = 0.119, P < 0.001).
Table 1 shows the characteristics of patients readmit-
ted within thirty days and of patients not requiring
hospital readmission within thirty days. Patients requir-
ing hospital readmission within thirty days were younger
and more likely to be African-American compared to
patients not readmitted within thirty days. Readmitted
patients had significantly more comorbidities as mani-
fested by significantly larger Charlson scores and indi-
vidual comorbidities including coronary artery disease,
congestive heart disease, peripheral vascular disease,
chronic obstructive pulmonary disease, connective tissue
disease, peptic ulcer disease, cirrhosis, diabetes mellitus,
paralysis, renal failure, underlying malignancy, lymph-
oma, and metastatic cancer. Patients with a thirty-day
readmission were more likely to be transferred to the
intensive care unit during their hospital stay, had longer
durations of hospitalization, more emergency depart-
ment visits in the six month period prior to their
hospitalization, significantly lower minimum hemoglobin
measurements during hospitalization, significantly higher
maximum serum creatinine values, and were more likely
to have Medicaid insurance compared to patients without
a thirty-day readmission.
Fig. 1 Prevalence of thirty-day hospital readmission as a function of
the number of discharge medications
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Table 2 shows the results of a multiple logistic regres-
sion model derivation to examine the variables associated
with thirty-day hospital readmission in this population. In
this model, more than one emergency department visit in
the previous six months was the strongest predictor of
thirty-day readmission, with an AOR of 2.37 (95 % CI,
2.19 to 2.57; P < 0.001). Other independent predictors of
thirty-day readmission included more than six discharge
medications, a minimum hemoglobin value less than or
equal to 9 g/dL, presence of peripheral vascular disease,
Table 1 Baseline Patient Characteristics
Variable 30-day Readmission P Value
Yes (N = 1147) No ( N = 4360)
Age, yrs 55.2 ± 17.7 56.4 ± 18.1 0.044
Gender: Male 545 (47.5) 2098 (48.1) 0.716
Female 602 (52.5) 2262 (51.9)
Race: Caucasian 523 (45.6) 2167 (49.7) 0.034
African-American 539 (47.0) 1919 (44.0)
Other 85 (7.4) 273 (6.3)
Median Income, dollars 30037 [24830,36763] 29281 [25118,37470] 0.631
Number of Discharge Medications 7 [4,10] 6 [3,9] <0.001
Charlson Comorbidity Score 5 [2,8] 3 [1,6] <0.001
ICU transfer during admission 171 (14.9) 541 (12.4) 0.025
Myocardial Infarction 203 (17.7) 525 (12.0) <0.001
Congestive Heart Failure 386 (33.7) 929 (21.3) <0.001
Peripheral Vascular Disease 207 (18.0) 430 (9.9) <0.001
Cardiovascular Disease 180 (15.7) 508 (11.7) <0.001
Dementia 37 (3.2) 101 (2.3) 0.080
Chronic Obstructive Pulmonary Disease 499 (43.5) 1375 (31.5) <0.001
Connective Tissue Disease 93 (8.1) 222 (5.1) <0.001
Peptic Ulcer Disease 124 (10.8) 283 (6.5) <0.001
Cirrhosis 118 (10.3) 208 (4.8) <0.001
Diabetes Mellitus without complications 260 (22.7) 843 (19.3) 0.012
Diabetes Mellitus with complications 207 (18.0) 433 (9.9) <0.001
Paralysis 76 (6.6) 173 (4.0) <0.001
Renal failure 376 (32.8) 873 (20.0) <0.001
Underlying Malignancy 99 (8.6) 250 (5.7) <0.001
Lymphoma 29 (2.5) 49 (1.1) <0.001
Metastatic Cancer 79 (6.9) 184 (4.2) <0.001
HIV 18 (1.6) 88 (2.0) 0.325
Minimum Hemoglobin, g/dLa 9.5 ± 2.3 10.4 ± 2.4 <0.001
Maximum Creatinine, mg/dLa 1.16 [0.81,2.14] 1.00 [0.77,1.50] <0.001
Length of Stay, days 4.1 [2.2,7.4] 3.0 [1.8,5.6] <0.001
Emergency Department visit in past 6 months 1 [0,3] 0 [0,2] <0.001
Admitted from Emergency Dept 817 (71.2) 3066 (70.3) 0.548
Insurance: Private 38 (3.3) 251 (5.8) <0.001
Medicare 184 (16.0) 961 (22.0)
Medicaid 554 (48.3) 1885 (43.2)
Patient Pay 49 (4.3) 390 (8.9)
Values expressed as mean ± standard deviation or median [25th percentile, 75th percentile]
Abbreviations: ICU intensive care unit; HIV human immunodeficiency virus
aDuring the hospitalization
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congestive heart failure, cirrhosis, and metastatic cancer.
The model had a good fit of the data with an R2 of 0.228.
Based on cross-validation, we did not observe overfitting.
The AORs for the variables that were significant predic-
tors in the model in all of the ten sequential reruns (with
90 % of the cohort) did not differ from the findings in the
complete population.
Risk scores for thirty-day readmission were derived by
converting the adjusted odds ratios for the independent
predictors of thirty-day readmission identified in the
multiple logistic regression analysis to risk scores as
shown in Table 2. The maximum possible risk score was
a value of 9.5. Figure 2 demonstrates the distribution of
calculated risk scores relative to the prevalence of thirty-
day hospital readmission. As the scores increased, so did
the probability of thirty-day readmission. For example,
among patients with a score of zero, the prevalence of
thirty-day readmission was approximately eleven percent,
while more than thirty-five percent of those with a score
greater than five had a thirty-day readmission (P < 0.001).
Figure 3 reveals the ROC curves for the risk score and the
number of discharge medications. As the ROC curves
document, the risk score had higher sensitivity than the
number of discharge medications for nearly the entire
range of specificities. Reflecting this, the area under the
ROC (AUROC) curve was greater for the risk score. The
AUROC curve for the number of discharge medications
equaled 0.579 (95 % CI, 0.560–0.598) whereas the
AUROC curve for the risk score was 14.0 % higher (0.661
[95 % CI, 0.643–0.679]; P = 0.030 for the difference in
AUROC curves).
A comparison of screening characteristics using the
number of discharge medications greater than six and a
risk score greater than zero for identifying patients with
a thirty-day readmission is presented in Table 3. Overall,
the risk score proved more accurate having greater sen-
sitivity and specificity compared to the number of dis-
charge medications alone.
Discussion
The main finding of this study was that the number of
medications at the time of hospital discharge was associ-
ated with unplanned rehospitalization within thirty days
in patients discharged from internal medicine units.
However, the overall predictive accuracy for thirty-day
readmission was found to be significantly better for a
risk score that incorporated the number of discharge
medications as one of the predictive elements, compared
to using the number of discharge medications as a sole
predictor. We also identified other predictors of thirty-
day readmission including the number of emergency
department visits in the previous six months, the mini-
mum hemoglobin value during hospitalization, presence
of congestive heart failure, peripheral vascular disease,
cirrhosis, and metastatic cancer.
Table 2 Variables Independently Associated with Thirty-Day Readmission
Variables OR 95 % CI P value Risk Score
Number of Discharge Medications >6 1.26 1.17–1.36 0.003 1.0
Number of ED visits > 1ab 2.37 2.19–2.57 <0.001 2.0
Minimum Hb value≤ 9 gm/dl 1.67 1.54–1.81 <0.001 1.5
Congestive Heart Failure 1.52 1.40–1.67 <0.001 1.5
Peripheral Vascular Disease 1.42 1.28–1.59 0.001 1.5
Cirrhosis 1.26 1.21–1.32 <0.001 1.0
Metastatic Cancer 1.08 1.06–1.11 0.002 1.0
aWithin 6 months of the index hospitalization
bCut-points for number of discharge medications, emergency department visits, and minimum Hg value were assessed by receiver-operating characteristic curves
as described in the Methods section
Abbrevations: OR odds ratio, CI confidence interval, ED emergency department, Hb hemoglobin
Fig. 2 Prevalence of thirty-day hospital readmission as a function of
the Risk Score. (See Methods section for a description of how the
Risk Score was calculated)
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Our results are consistent with those recently published
from other settings. Wimmer et al. examined a small co-
hort of patients discharged from a geriatric unit in
Australia and found that medication regimen complexity
was not associated with unplanned hospital readmission
in older people [9]. However, in patients discharged to
nonhome settings, the number of discharge medications
predicted rehospitalization suggesting that a patient’s dis-
charge destination may be an important factor in un-
planned medication-related readmissions [9]. A recent
systematic review also found that hospitalization resulting
from medication related problems was common with the
main causes being adverse drug reactions and medication
non-compliance [10]. This review also found that old age
and polypharmacy were highly represented among pa-
tients admitted to hospitals due to medication related
problems [10]. Our study further highlights the nature
and extent of medication-related hospitalizations in sev-
eral ways. First, increasing medication use is likely a
surrogate marker of disease severity and complexity mak-
ing it a good marker for readmission risk. Secondly, as the
number of medications increases it is more likely that pa-
tients will not be compliant with all prescribed medica-
tions due to either cost issues, side effects, or inability to
keep accurate tracking of all their medication
consumption.
Quality improvement programs have been imple-
mented to reduce the number and complexity of dis-
charge medications in order to minimize adverse events
and to improve compliance. A pharmacist-directed dis-
charge medication management program has been
shown to be successful in decreasing both number and
type of discharge medications [11]. Overall, patient sys-
tem readmission rates were also significantly decreased
in association with implementation of the discharge
medication management program [11]. However, other
programs aimed at minimizing problems with discharge
medications to include education and medication rec-
onciliation have not been able to show reductions in
the occurrence of hospital readmission [12, 13]. These
studies would suggest that the intricacy of discharge
medications, to include their overall number, may sim-
ply reflect the global medical complexity of patients
which is the more important overall determinant of
subsequent readmission [14].
The difficulty of understanding the determinants of
readmission and reducing readmission events is illus-
trated by several recent studies. Kangovi et al. per-
formed a randomized trial at two hospitals randomizing
usual care versus creating individualized action plans
for achieving patients’ stated goals for recovery prior to
discharge administered by community health workers
[15]. Although medication adherence was not influ-
enced by this intervention, timely posthospital primary
care and high-quality discharge communication occurred
resulting in fewer multiple thirty-day readmissions. Simi-
larly, Hochhalter et al. carried out a retrospective study to
test the association of long-term medication adherence
with hospital readmission in a cohort of beneficiaries en-
rolled in a Medicare Cost Plan [16]. They found that
medication adherence was not associated with thirty-day
readmission, but older age and longer length of hospital
stay were associated with higher likelihood of thirty-day
readmission, while having an office visit within thirty days
of discharge was associated with lower odds of readmis-
sion [16]. Dharmarajan et al. showed in a large database
that readmissions following congestive heart failure, acute
myocardial infarction, and pneumonia hospitalization
were diverse and usually for a different reason than the
original hospitalization problem [14]. Taken together,
these studies illustrate the complexity of identifying
specific interventions, such as improved medication ad-
herence, in order to reduce readmissions. These studies
Table 3 Screening Characteristics of the Number of Discharge
Medications Versus Risk Score
Characteristic Sensitivity Specificity PPV NPV Accuracy
Number of Discharge
Medications >6
53.8 57.5 25.0 82.5 56.7
Risk Score > 0 83.4 65.4 25.1 93.8 69.1
Abbreviations: PPV positive predictive value; NPV negative predictive value
Fig. 3 Receiver-operating characteristic curves.
Abbreviation: Meds = medications
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also suggest that more general interventions such as
early posthospital follow up visits may be more import-
ant means of preventing readmissions.
Our study has several important limitations. First, this
was a retrospective analysis. It is possible that we did not
identify all patient variables and processes of care that are
important determinants of thirty-day readmission in this
population. Moreover, the retrospective nature of this
investigation did not allow an assessment of medication
adherence as it relates to the number of discharge medica-
tions. Second, we simply examined the number of discharge
medications without determining whether certain classes of
discharge medications were more likely to be associated
with thirty-day readmission. Third, we did not have access
to outpatient visits following the index hospitalization. Sev-
eral studies have identified timely posthospital discharge as
an important process for the prevention of readmissions
[15, 16]. Fourth, this was a single-center study in a medical
population, which limits the generalizability of our findings.
Additionally, the patient population at Barnes-Jewish
Hospital may not be representative of that at other centers.
For example, the mean age of our population is younger
than that reported in other studies examining risk factors
for hospital readmission [16]. However, a strength of our
study is that we did not limit inclusion to patients with
specific diseases. We also did not examine other poten-
tially important predictors of hospital readmission to in-
clude the presence of delirium. Finally, we did not account
for patients who died within thirty days after hospital dis-
charge. These represent discharged patients that could not
be readmitted but who may have shared characteristics of
the patients at high risk for readmission. However, we
found that the number of discharge medications was asso-
ciated with the prevalence of thirty-day readmission des-
pite this bias adding to the robustness of our findings.
Conclusions
The number of discharge medications was found to be
associated with the prevalence of thirty-day hospital re-
admission. A risk score that includes the number of dis-
charge medications accurately predicts patients at risk for
thirty-day readmission. Our findings suggest that relatively
simple and accessible parameters can identify patients at
high risk for hospital readmission potentially distin-
guishing such individuals for interventions to minimize
readmissions.
Abbreviations
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